TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy

Cytokine

Volumn 64, Issue 1, 2013, Pages 43-45

  Novoyatleva, Tatyana ^a   Janssen, Wiebke ^a   Wietelmann, Astrid ^a   Schermuly, Ralph T ^a,b   Engel, Felix B ^a,c  

^a MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

FN14; Hypertrophy; Right heart; TWEAK

Indexed keywords

FIBROBLAST GROWTH FACTOR INDUCIBLE MOLECULE 14; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CELL GROWTH; CELL SIZE; CONTROLLED STUDY; HEART MUSCLE CELL; HEART RIGHT VENTRICLE HYPERTROPHY; IN VITRO STUDY; LUNG ARTERY BANDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

MUS; RATTUS;

FIBROBLAST GROWTH FACTOR-INDUCIBLE MOLECULE 14; FN14; HYPERTROPHY; LEFT VENTRICULAR; LV; MAGNETIC RESONANCE IMAGING; MRI; PAB; PULMONARY ARTERY BANDING; RIGHT HEART; RIGHT VENTRICULAR; RV; TNF-LIKE WEAK INDUCER OF APOPTOSIS; TWEAK;

ANIMALS; CELLS, CULTURED; HEART; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; MICE; MICE, KNOCKOUT; MYOCARDIUM; MYOCYTES, CARDIAC; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION;

EID: 84883554988     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.05.009     Document Type: Article

References (11)

1. Gaasch W.H., Delorey D.E., St John Sutton M.G., Zile M.R. Patterns of structural and functional remodeling of the left ventricle in chronic heart failure. Am J Cardiol 2008, 102:459-462.
2. McKinsey T.A., Kass D.A. Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. Nat Rev Drug Discov 2007, 6:617-635.
3. Wiley S.R., Winkles J.A. TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor. Cytokine Growth Factor Rev 2003, 14:241-249.
4. Novoyatleva T., Diehl F., van Amerongen M.J., Patra C., Ferrazzi F., Bellazzi R., et al. TWEAK is a positive regulator of cardiomyocyte proliferation. Cardiovasc Res 2010, 85:681-690.
5. Dogra C., Hall S.L., Wedhas N., Linkhart T.A., Kumar A. Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesis. J Biol Chem 2007, 282:15000-15010.
6. Feng S.L., Guo Y., Factor V.M., Thorgeirsson S.S., Bell D.W., Testa J.R., et al. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. Am J Pathol 2000, 156:1253-1261.
7. Girgenrath M., Weng S., Kostek C.A., Browning B., Wang M., Brown S.A., et al. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. Embo J 2006, 25:5826-5839.
8. Mustonen E., Sakkinen H., Tokola H., Isopoussu E., Aro J., Leskinen H., et al. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats. Acta Physiol (Oxf) 2010, 199:11-22.
9. Sanz A.B., Sanchez-Nino M.D., Ortiz A. TWEAK, a multifunctional cytokine in kidney injury. Kidney Int 2011, 80:708-718.
10. Jain M., Jakubowski A., Cui L., Shi J., Su L., Bauer M., et al. A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 2009, 119:2058-2068.
11. Novoyatleva T., Schymura Y., Janssen W., Strobl F., Swiercz J.M., Patra C., et al. Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction. Basic Res Cardiol 2013, 108:325.